BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, Dalekos GN. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World J Gastroenterol 2005; 11(4): 482-487 [PMID: 15641130 DOI: 10.3748/wjg.v11.i4.482]
URL: https://www.wjgnet.com/1007-9327/full/v11/i4/482.htm
Number Citing Articles
1
Panagiotis A Papamichalis, Kalliopi Zachou, George K Koukoulis, Aikaterini Veloni, Efthimia G Karacosta, Lampros Kypri, Ioannis Mamaloudis, Stella Gabeta, Eirini I Rigopoulou, Ansgar W Lohse, George N Dalekos. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disordersJournal of Autoimmune Diseases 2007; 4(1) doi: 10.1186/1740-2557-4-3
2
Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Autoantibodies in chronic hepatitis C: A clinical perspectiveWorld Journal of Hepatology 2015; 7(8): 1074-1085 doi: 10.4254/wjh.v7.i8.1074
3
Eirini I Rigopoulou, Kalliopi Zachou, Nikolaos K Gatselis, Georgia Papadamou, George K Koukoulis, George N Dalekos. Primary biliary cirrhosis in HBV and HCV patients: Clinical characteristics and outcomeWorld Journal of Hepatology 2013; 5(10): 577-583 doi: 10.4254/wjh.v5.i10.577
4
Holger G. Hass, Reinhild Klein, Oliver Nehls, Stephan Kaiser. Thyroid Disorders and Occurrence of Nonorgan-specific Autoantibodies (NOSA) in Patients With Chronic Hepatitis C Before and During Antiviral Induction Therapy With Consensus Interferon (Interferon Alfacon-1)Journal of Clinical Gastroenterology 2009; 43(5): 470 doi: 10.1097/MCG.0b013e318184a470
5
N. K. GATSELIS, S. P. GEORGIADOU, G. K. KOUKOULIS, N. TASSOPOULOS, K. ZACHOU, C. LIASKOS, A. HATZAKIS, G. N. DALEKOS. Clinical significance of organ‐ and non‐organ‐specific autoantibodies on the response to anti‐viral treatment of patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics 2006; 24(11-12): 1563 doi: 10.1111/j.1365-2036.2006.03165.x
6
Silvia Ferri, Luigi Muratori, Chiara Quarneti, Paolo Muratori, Rita Menichella, Georgios Pappas, Alessandro Granito, Giorgio Ballardini, Francesco B. Bianchi, Marco Lenzi. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis CJournal of Hepatology 2009; 50(6): 1093 doi: 10.1016/j.jhep.2009.02.020
7
Hideki Niwa, Motoko Sasaki, Joji Haratake, Takahiko Kasai, Kazuyoshi Katayanagi, Hiroshi Kurumaya, Shinji Masuda, Hiroshi Minato, You Zen, Akio Uchiyama, Atsuo Miwa, Katsuhiko Saito, Yoshiko Sudo, Yasuni Nakanuma. Clinicopathological significance of antinuclear antibodies in non‐alcoholic steatohepatitisHepatology Research 2007; 37(11): 923 doi: 10.1111/j.1872-034X.2007.00150.x
8
Aikaterini Tsikrikoni, Eirini I Rigopoulou, Kalliopi Zachou, Christos Liaskos, Despina Kyriakou, George N Dalekos. Bone marrow findings in patients with autoimmune liver diseasesJournal of Gastroenterology and Hepatology 2008; 23(8pt2) doi: 10.1111/j.1440-1746.2008.05309.x
9
Aggeliki Lyberopoulou, Georgia Chachami, Nikolaos K. Gatselis, Eleni Kyratzopoulou, Asterios Saitis, Stella Gabeta, Petros Eliades, Efrosini Paraskeva, Kalliopi Zachou, George K. Koukoulis, Avgi Mamalaki, George N. Dalekos, George Simos, Pavel Strnad. Low Serum Hepcidin in Patients with Autoimmune Liver DiseasesPLOS ONE 2015; 10(8): e0135486 doi: 10.1371/journal.pone.0135486
10
Aglaia Zellos, Vana Spoulou, Eleftheria Roma-Giannikou, Ourania Karentzou, George N. Dalekos, Maria Theodoridou. Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?Annals of Hepatology 2013; 12(1): 147 doi: 10.1016/S1665-2681(19)31398-5
11
Nikolaos K Gatselis, Tamás Tornai, Zakera Shums, Kalliopi Zachou, Asterios Saitis, Stella Gabeta, Roger Albesa, Gary L Norman, Mária Papp, George N Dalekos. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patientsWorld Journal of Gastroenterology 2020; 26(34): 5130-5145 doi: 10.3748/wjg.v26.i34.5130
12
Eirini I Rigopoulou, Maria Mytilinaiou, Ourania Romanidou, Christos Liaskos, George N Dalekos. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitisJournal of Autoimmune Diseases 2007; 4(1) doi: 10.1186/1740-2557-4-2